Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15338 | 647 | 27.6 | 49% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 810 | 11347 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AUXOTROPHIC EDWARDSIELLA TARDA MUTANT | Author keyword | 1 | 50% | 0% | 1 |
| 2 | CAS 51 45 6 | Author keyword | 1 | 50% | 0% | 1 |
| 3 | CIMETIDINE THERAPEUTIC USE | Author keyword | 1 | 50% | 0% | 1 |
| 4 | FORMYLMETHIONYL PEPTIDES | Author keyword | 1 | 50% | 0% | 1 |
| 5 | GASTROENTEROL PRACTICES | Address | 1 | 50% | 0% | 1 |
| 6 | HISTAMINE RECEPTOR 2 ANTAGONISTS | Author keyword | 1 | 50% | 0% | 1 |
| 7 | HUMAN SALIVARY GLAND TUMOR CELL | Author keyword | 1 | 50% | 0% | 1 |
| 8 | IMMUNOAUGMENTATION | Author keyword | 1 | 50% | 0% | 1 |
| 9 | KILLER CELL ACTIVITY | Author keyword | 1 | 50% | 0% | 1 |
| 10 | LOWER SILESIAN | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SUPPRESSOR FACTOR HSF | 13 | 71% | 2% | 10 |
| 2 | POSTOPERATIVE SUPPRESSION | 6 | 47% | 1% | 9 |
| 3 | TISSUE HISTAMINE | 3 | 57% | 1% | 4 |
| 4 | TREATMENT RESISTANT PSORIASIS | 2 | 67% | 0% | 2 |
| 5 | INDUCED SUPPRESSOR FACTOR | 2 | 50% | 0% | 3 |
| 6 | ANTAGONIST IMMUNE MODULATION | 1 | 100% | 0% | 2 |
| 7 | ENHANCES LYMPHOCYTE INFILTRATION | 1 | 100% | 0% | 2 |
| 8 | LEUKOCYTES HRL | 1 | 100% | 0% | 2 |
| 9 | INVITRO HUMORAL IMMUNITY | 1 | 40% | 0% | 2 |
| 10 | HISTAMINE 2 RECEPTOR ANTAGONISTS | 1 | 19% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer | 2012 | 2 | 36 | 53% |
| Does cimetidine improve prospects for cancer patients? A reappraisal of the evidence to date | 1999 | 11 | 19 | 79% |
| Cimetidine: An anticancer drug? | 2011 | 17 | 84 | 36% |
| HISTAMINE MODULATION OF LYMPHOCYTE BIOLOGY - MEMBRANE-RECEPTORS, SIGNAL TRANSDUCTION, AND FUNCTIONS | 1987 | 79 | 79 | 73% |
| THE INFLUENCE OF HISTAMINE ON IMMUNE AND INFLAMMATORY RESPONSES | 1984 | 140 | 55 | 67% |
| IMMUNOMODULATION BY HISTAMINE | 1990 | 11 | 30 | 83% |
| LYMPHOCYTE HORMONE RECEPTORS | 1987 | 170 | 174 | 22% |
| Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma | 2006 | 23 | 93 | 32% |
| POSSIBLE ROLE OF HISTAMINE-2 RECEPTOR ANTAGONISTS FOR ADJUVANT TREATMENT IN COLORECTAL-CANCER | 1991 | 15 | 66 | 39% |
| HISTAMINE AND ITS LYMPHOCYTE-SELECTIVE DERIVATIVES AS IMMUNE MODULATORS | 1987 | 29 | 16 | 75% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GASTROENTEROL PRACTICES | 1 | 50% | 0.2% | 1 |
| 2 | LOWER SILESIAN | 1 | 50% | 0.2% | 1 |
| 3 | ST GEORGE HOSP SURG | 1 | 50% | 0.2% | 1 |
| 4 | UNIBIOSCREEN SA | 1 | 50% | 0.2% | 1 |
| 5 | UROL TRANSPLANTAT UNIT | 1 | 50% | 0.2% | 1 |
| 6 | HEPATOBILIARY SURG FUJIAN PROV | 0 | 25% | 0.2% | 1 |
| 7 | ORAL CARE CLIN | 0 | 25% | 0.2% | 1 |
| 8 | TEACHING HOSP 2NAKAGAWA KU | 0 | 25% | 0.2% | 1 |
| 9 | TRAINING PROGRAM BIOMED INFORMAT | 0 | 25% | 0.2% | 1 |
| 10 | SURG GASTROENTEROL 235 | 0 | 12% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000245043 | HISTAMINE H 4 RECEPTOR//HISTIDINE DECARBOXYLASE//JNJ7777120 |
| 2 | 0.0000110334 | POLLENOSES//TREATMENT OF CHILDREN//GASTRODUODENAL ZONE |
| 3 | 0.0000105247 | MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL |
| 4 | 0.0000081168 | FC 215//ACUTE HYPERSENSITIVITY PNEUMONITIS//HUMAN ANTIMURINE ANTIBODY |
| 5 | 0.0000078143 | 5HT3A//NUTR CELLULAIRE METAB//UNITE IMMUNOPHYSIOL GEN COMPAREE |
| 6 | 0.0000076513 | CLIN SURG UNIT//INTEGRATED SECT TRANSLAT MED ONCOL//DIAGNOST INTERVENT RADIOL UNIT |
| 7 | 0.0000073352 | SKIN CHAMBER//LATE PHASE REACTIONS//CUTANEOUS ALLERGIC REACTIONS |
| 8 | 0.0000071441 | ISOFATTY ACID//COOPERAT MED//MNSF BETA |
| 9 | 0.0000070344 | AUTOIMMUNE GASTRITIS//EXPERIMENTAL AUTOIMMUNE GASTRITIS//NEONATAL THYMECTOMY |
| 10 | 0.0000067339 | POSTOPERATIVE SEPTIC COMPLICATIONS//BRIAN MIND//LOOSENING OF ENDOPROSTHESES |